Literature DB >> 18317830

Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma.

Federico Boschi1, Pasquina Marzola, Marco Sandri, Elena Nicolato, Mirco Galiè, Silvia Fiorini, Flavia Merigo, Vito Lorusso, Linda Chaabane, Andrea Sbarbati.   

Abstract

OBJECTIVE: The aim of this study was to compare a pure macromolecular contrast agent (Gd-DTPA-albumin) with a new protein-binding blood pool contrast agent (B22956/1) in terms of their capacity to investigate the microvasculature in an experimental model of mammary carcinoma.
MATERIALS AND METHODS: Tumors were induced by subcutaneous injection of 5 x 10(5) BB1 cells into the backs of 5-7 week-old female FVB/neuNT233 mice. The animals were observed using DCE-MRI when the longest diameter of the tumor was 10.2+/-2.0 mm. DCE-MRI experiments were carried out using B22956/1 and (24 h later) Gd-DTPA-albumin.
RESULTS: DCE-MRI data showed that vasculature in the tumor rim was characterized by greater fractional plasma volume and transendothelial permeability than vasculature in the tumor core as measured by both contrast agents. Permeability to Gd-DTPA-albumin in the tumor core was hardly measurable while permeability to B22956/1 was substantial. Histologically the tumor core showed areas of well vascularized, viable tissue surrounded by necrotic regions.
CONCLUSIONS: DCE-MRI experiments performed with B22956/1 are useful in the investigation of vasculature in those tumor regions that are characterized by low permeability to macromolecules.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18317830     DOI: 10.1007/s10334-008-0106-6

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  24 in total

1.  MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology.

Authors:  K Turetschek; E Floyd; T Helbich; T P Roberts; D M Shames; M F Wendland; W O Carter; R C Brasch
Journal:  J Magn Reson Imaging       Date:  2001-09       Impact factor: 4.813

2.  Effect of tamoxifen in an experimental model of breast tumor studied by dynamic contrast-enhanced magnetic resonance imaging and different contrast agents.

Authors:  Pasquina Marzola; Simona Ramponi; Elena Nicolato; Emanuela Lovati; Marco Sandri; Laura Calderan; Caterina Crescimanno; Flavia Merigo; Andrea Sbarbati; Adriana Grotti; Stefania Vultaggio; Friederich Cavagna; Vito Lorusso; Francesco Osculati
Journal:  Invest Radiol       Date:  2005-07       Impact factor: 6.016

Review 3.  Imaging tumour angiogenesis.

Authors:  Tony Jeswani; Anwar R Padhani
Journal:  Cancer Imaging       Date:  2005-12-01       Impact factor: 3.909

4.  Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model.

Authors:  Venu Raman; Dmitri Artemov; Arvind P Pathak; Paul T Winnard; Stephen McNutt; Anna Yudina; Alexei Bogdanov; Zaver M Bhujwalla
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

5.  Pre-clinical results with Clariscan (NC100150 Injection); experience from different disease models.

Authors:  A Bjørnerud; L O Johansson; H K Ahlström
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.310

6.  Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.

Authors:  H Daldrup; D M Shames; M Wendland; Y Okuhata; T M Link; W Rosenau; Y Lu; R C Brasch
Journal:  Pediatr Radiol       Date:  1998-02

7.  Dynamic contrast-enhanced MRI using macromolecular contrast media for monitoring the response to isolated limb perfusion in experimental soft-tissue sarcomas.

Authors:  A Preda; P A Wielopolski; T L M Ten Hagen; M van Vliet; J F Veenland; G Ambagtsheer; S T van Tiel; M W Vogel; A M M Eggermont; G P Krestin; C F van Dijke
Journal:  MAGMA       Date:  2004-10-10       Impact factor: 2.310

8.  Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470.

Authors:  Zaver M Bhujwalla; Dmitri Artemov; Kshama Natarajan; Meiyappan Solaiyappan; Peggy Kollars; Paul E G Kristjansen
Journal:  Clin Cancer Res       Date:  2003-01       Impact factor: 12.531

Review 9.  Imaging of angiogenesis: from microscope to clinic.

Authors:  Donald M McDonald; Peter L Choyke
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

10.  Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights.

Authors:  Karl Turetschek; Anda Preda; Viktor Novikov; Robert C Brasch; Hanns J Weinmann; Patrick Wunderbaldinger; Timothy P L Roberts
Journal:  J Magn Reson Imaging       Date:  2004-07       Impact factor: 4.813

View more
  10 in total

1.  Pharmacokinetics and magnetic resonance imaging of biodegradable macromolecular blood-pool contrast agent PG-Gd in non-human primates: a pilot study.

Authors:  Mei Tian; Xiaoxia Wen; Edward F Jackson; Chaan Ng; Rajesh Uthamanthil; Dong Liang; Juri G Gelovani; Chun Li
Journal:  Contrast Media Mol Imaging       Date:  2011-01-06       Impact factor: 3.161

2.  Multivalent protein polymer MRI contrast agents: controlling relaxivity via modulation of amino acid sequence.

Authors:  Lindsay S Karfeld-Sulzer; Emily A Waters; Nicolynn E Davis; Thomas J Meade; Annelise E Barron
Journal:  Biomacromolecules       Date:  2010-06-14       Impact factor: 6.988

3.  Breast cancer redox heterogeneity detectable with chemical exchange saturation transfer (CEST) MRI.

Authors:  Kejia Cai; He N Xu; Anup Singh; Lily Moon; Mohammad Haris; Ravinder Reddy; Lin Z Li
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

Review 4.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

5.  B25716/1: a novel albumin-binding Gd-AAZTA MRI contrast agent with improved properties in tumor imaging.

Authors:  E Gianolio; C Cabella; S Colombo Serra; G Valbusa; F Arena; A Maiocchi; L Miragoli; F Tedoldi; F Uggeri; M Visigalli; P Bardini; S Aime
Journal:  J Biol Inorg Chem       Date:  2014-02-08       Impact factor: 3.358

Review 6.  Recent developments in vascular imaging techniques in tissue engineering and regenerative medicine.

Authors:  Paul Kumar Upputuri; Kathyayini Sivasubramanian; Chong Seow Khoon Mark; Manojit Pramanik
Journal:  Biomed Res Int       Date:  2015-03-02       Impact factor: 3.411

Review 7.  In vivo imaging techniques: a new era for histochemical analysis.

Authors:  A Busato; P Fumene Feruglio; P P Parnigotto; P Marzola; A Sbarbati
Journal:  Eur J Histochem       Date:  2016-11-28       Impact factor: 3.188

Review 8.  Contrast agents in dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Yuling Yan; Xilin Sun; Baozhong Shen
Journal:  Oncotarget       Date:  2017-06-27

9.  Heterogeneous Enhancement Pattern in DCE-MRI Reveals the Morphology of Normal Lymph Nodes: An Experimental Study.

Authors:  Pietro Bontempi; Alice Busato; Giamaica Conti; Sabino Walter Della Sala; Pasquina Marzola; Paolo Farace
Journal:  Contrast Media Mol Imaging       Date:  2019-04-04       Impact factor: 3.161

Review 10.  Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations.

Authors:  Michael J Thrippleton; Walter H Backes; Steven Sourbron; Michael Ingrisch; Matthias J P van Osch; Martin Dichgans; Franz Fazekas; Stefan Ropele; Richard Frayne; Robert J van Oostenbrugge; Eric E Smith; Joanna M Wardlaw
Journal:  Alzheimers Dement       Date:  2019-04-25       Impact factor: 21.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.